Delivery Order SPE2DB20D3101-SPE2DB23FQZY9
Award Date
1/12/23
Potential Completion Date
1/13/23
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Loryna 3 mg-0.02 mg tablet, 28-count. The contract has a total ceiling value of $2,057.63 and a period of performance ending on August 2, 2024. The contract is a firm-fixed price type with no set-aside designation. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, will deliver the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S." The contract award, valued at $1,298.40, has an ultimate completion date of April 1, 2024. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
This federal contract award, valued at $3,718.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Loryna 3 mg-0.02 mg tablets, a type of oral contraceptive medication, with a completion date of September 23, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,629.25, is for the supply of LORYNA 3 MG-0.02 MG tablets in 28-count packages. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical drug Loryna 3 mg-0.02 mg tablet, 28 count. The contract has a total ceiling value of $3,004.73 and runs through October 18, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with a potential value of $1,450.40 and a completion date of January 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded by DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.44 firm fixed-price contract is for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, to be delivered by February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The order is for the supply of Loryna 3 mg-0.02 mg tablet, a prescription medication. The total ceiling value of this delivery order is $1,266.72, with a firm fixed price and an ultimate completion date of September 13, 2024. The contract does not have a set-aside designation....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $1,388.10 and a period of performance through July 12, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $2,154.85, is for the delivery of a pharmaceutical product, specifically Loryna 3 mg-0.02 mg tablets in 28-count packages. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00...